Cipla, Glenmark recall drugs in US due to manufacturing issues
New Delhi: Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues. In ...
Read moreNew Delhi: Drug makers Cipla and Glenmark are recalling their products from the US market due to manufacturing issues. In ...
Read moreNew Delhi: Glenmark Pharmaceuticals Tuesday it will pay $87.5 million to three plaintiff groups to settle multiple antitrust and consumer ...
Read moreNew Delhi: Drug major Glenmark Pharma Thursday said it has received final approval from the US health regulator for Tadalafil ...
Read moreNew Delhi: Glenmark Pharmaceuticals, a research-led global pharmaceutical company, Thursday announced that it is set to introduce a 400 mg ...
Read moreNew Delhi: Glenmark Pharmaceuticals said Wedensday that the Phase 3 clinical trial of antiviral drug Favipiravir is giving hope. Glenmark ...
Read moreNew Delhi: Indian drug majors Lupin, Sun Pharma and Glenmark Pharmaceuticals are recalling various drugs from the US market for ...
Read more